348 related articles for article (PubMed ID: 11232678)
1. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.
Lee HR; Lennon VA; Camilleri M; Prather CM
Am J Gastroenterol; 2001 Feb; 96(2):373-9. PubMed ID: 11232678
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic gastrointestinal dysmotility: when to consider and how to diagnose.
DiBaise JK
Gastroenterol Clin North Am; 2011 Dec; 40(4):777-86. PubMed ID: 22100117
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
Lucchinetti CF; Kimmel DW; Lennon VA
Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic and clinical study of paraneoplastic limbic encephalitis].
Chen Q; Li Q; Qian W; Tang Q; Liu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Dec; 20(6):466-9. PubMed ID: 11717941
[TBL] [Abstract][Full Text] [Related]
5. [Neurologic syndromes associated with anti-Hu antibody. Study of 24 patients].
Valldeoriola F; Vega F; Reñé R; Pou A; Roquer J; Delattre JY; Graus F
Med Clin (Barc); 1992 Oct; 99(10):361-4. PubMed ID: 1334171
[TBL] [Abstract][Full Text] [Related]
6. Severe paraneoplastic gastroparesis associated with anti-Hu antibodies preceding the manifestation of small-cell lung cancer.
Nguyen-tat M; Pohl J; Günter E; Manner H; Plum N; Pech O; Ell C
Z Gastroenterol; 2008 Mar; 46(3):274-8. PubMed ID: 18322883
[TBL] [Abstract][Full Text] [Related]
7. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
8. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy.
Budde-Steffen C; Anderson NE; Rosenblum MK; Posner JB
Cancer Res; 1988 Jan; 48(2):430-4. PubMed ID: 2825975
[TBL] [Abstract][Full Text] [Related]
9. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
10. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
11. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.
Titulaer MJ; Wirtz PW; Willems LN; van Kralingen KW; Smitt PA; Verschuuren JJ
J Clin Oncol; 2008 Sep; 26(26):4276-81. PubMed ID: 18779614
[TBL] [Abstract][Full Text] [Related]
12. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
[TBL] [Abstract][Full Text] [Related]
13. [Abdominal complaints and neurological symptoms as an early sign of lung cancer: a manifestation of the anti-Hu syndrome].
Wymenga AN; Slebos DJ; van der Naalt J; van Putten JW; Peters FT
Ned Tijdschr Geneeskd; 2003 Mar; 147(13):616-9. PubMed ID: 12701397
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic dysmotility: loss of interstitial cells of Cajal.
Pardi DS; Miller SM; Miller DL; Burgart LJ; Szurszewski JH; Lennon VA; Farrugia G
Am J Gastroenterol; 2002 Jul; 97(7):1828-33. PubMed ID: 12135044
[TBL] [Abstract][Full Text] [Related]
15. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity.
Vernino S; Lennon VA
Ann Neurol; 2000 Mar; 47(3):297-305. PubMed ID: 10716248
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
17. [Three patients with a paraneoplastic neurological syndrome: the significance of paraneoplastic antibodies].
Smitt PA; Polman SK; de Beukelaar JW; Enting RH; van den Bent MJ; Bromberg JE; Kros JM; Hooijkaas H
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):874-80. PubMed ID: 17472120
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic intestinal pseudo-obstruction, mononeuritis multiplex, and sensory neuropathy/neuronopathy.
Simpson DA; Pawlak AM; Tegmeyer L; Doig C; Cox D
J Am Osteopath Assoc; 1996 Feb; 96(2):125-8. PubMed ID: 8838909
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological study of the paraneoplastic neuromuscular syndromes associated with lung cancer.
Gomm SA; Thatcher N; Barber PV; Cumming WJ
Q J Med; 1990 Jun; 75(278):577-95. PubMed ID: 2171009
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological advances on central nervous system paraneoplastic syndromes.
Graus F; René R
Rev Neurol (Paris); 1992; 148(6-7):496-501. PubMed ID: 1448670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
